Literature DB >> 31119791

miR-885-5p plays an accomplice role in liver cancer by instigating TIGAR expression via targeting its promoter.

Shubiao Zou1, Yao Rao2, Weicai Chen3.   

Abstract

TIGAR (TP53-induced glycolysis and apoptosis regulator) is a p53-inducible gene and its expression resulted in controlling metabolism and protection from apoptosis. Furthermore, TIGAR participated in promoting the pentose phosphate pathway and help in lowering intracellular reactive oxygen species. miR-885-5p has also been reported to be involved in liver tumorigenesis, but whether miR-885-5p has a regulatory effect on TIGAR expression is unknown. In this study, we found that their levels were correlated to each other and positively related to cell malignancy. Exogenous miR-885-5p induced TIGAR expression through a p53-independent pathway. The promoter region of TIGAR harbors two tandem putative miR-885-5p target sites. Cotransfection of synthetic miR-885 with TIGAR promoter reporter constructs significantly enhanced TIGAR promoter activity via binding with target sites. Furthermore, miR-885-5p and its precursor pre-miR-885 had the same stimulatory impact on TIGAR expression. Chromatin immunoprecipitation analysis further verified that increased miR-885-5p potentiated the accessibility of TIGAR promoter chromatin to transcriptional factors and facilitated TIGAR expression. miR-885-5p and its precursor both can interact mechanically with TIGAR promoter binding site and alter local chromatin structure, and subsequently upregulate TIGAR expression and participate in liver tumorigenesis.
© 2019 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  TP53-inducible glycolysis and apoptosis regulator (TIGAR); hepatocellular carcinoma (HCC); miR-885-5p; promoter activity; regulatory effect

Mesh:

Substances:

Year:  2019        PMID: 31119791     DOI: 10.1002/bab.1767

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  6 in total

1.  Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival.

Authors:  Swagoto Mukhopadhyay; Yoshihisa Tokumaru; Masanori Oshi; Itaru Endo; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

Review 2.  Structure, regulation, and biological functions of TIGAR and its role in diseases.

Authors:  Jie Tang; Lei Chen; Zheng-Hong Qin; Rui Sheng
Journal:  Acta Pharmacol Sin       Date:  2021-01-28       Impact factor: 7.169

Review 3.  Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression.

Authors:  Lei Zhang; Xiulan Zheng; Wen Cheng; Xuefei Zhang; Lingling Wang; Haixia Li
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

4.  The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature.

Authors:  Zongxing Yang; Yuhan Yang; Gang Zhou; Yan Luo; Wenjun Yang; Youliang Zhou; Jin Yang
Journal:  J Cancer       Date:  2020-04-12       Impact factor: 4.207

5.  Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma.

Authors:  Xin Zhao; Xinxue Zhang; Zhigang Zhang; Zhe Liu; Jiqiao Zhu; Shaocheng Lyu; Lixin Li; Ren Lang; Qiang He
Journal:  Aging (Albany NY)       Date:  2020-11-18       Impact factor: 5.682

Review 6.  The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma.

Authors:  Siqi Zhao; Wubin Zheng; Chao Yu; Gaoxin Xu; Xinyi Zhang; Chao Pan; Yongheng Feng; Kunxing Yang; Jin Zhou; Yong Ma
Journal:  Front Cell Dev Biol       Date:  2022-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.